MarketInOut Stock Screener Log In | Sign Up

CorMedix Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
CorMedix Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization452.08 mln
Float71.48 mln
Earnings Date11/11/2026

EPS

2.05
Solid

P / E

2.78
Deeply undervalued

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

17.57
Highly suspicious

Relative Strength

2 / 100
Severely lagging

Debt / Equity

0.32
Low leverage

Business Description

CorMedix is a New Jersey-based medical company working to protect seriously ill patients from dangerous infections. Its flagship product, DefenCath, is a solution used to clean and seal dialysis catheters, helping to prevent life-threatening bloodstream infections in people with kidney failure. The company has been operating under its current name since 2007.

Key Fundamentals

EPS2.05
P/E2.78
ROE49.31
RPS5.91
ROIC45.61
ROA25.99
Interest Cover78.49
EBITDA, mln242
EV / EBITDA2.60
EV / EBIT3.04
Revenue, mln462
EV / Revenue1.36

Quote Details

Last 5.70
Change -1.94 (-25.39%)
Open 7.68
Volume 7,266,805
Turnover 41,420,788
Average Volume 1,470,476

Financial Ratios

Pre-Tax Profit Margin44
Leverage Ratio1.96
Current Ratio2.56
Price / Book1.35
Price / Tangible Book8.60
Price / Cash Flow1.83
Price / Free Cash Flow2.95
Debt / Equity0.32
Price / Sales1.58
PEG Ratio5.46

Financial Strength

Altman Z-Score2.32
Piotroski F-Score 3 / 9
Beneish M-Score17.57
Price to Intrinsic Value1.24
Price to Graham Number1.18
Short Ratio14.92
Short % of Float19.07

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -27.39% 1 / 100   
1 Month -23.18% 4 / 100   
2 Months -25% 7 / 100   
6 Months -26.83% 10 / 100   
1 Year -49.6% 5 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog